Patel Samir Rashmikant 13D and 13G filings for Akari Therapeutics, Plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-06 4:00 pm Purchase |
2024-11-14 | 13D | Akari Therapeutics, Plc AKTX |
Patel Samir Rashmikant | 5,745,834,167 10.850% |
2,332,672,000 (+68.34%) |
Filing |
| 2024-06-07 6:00 pm Purchase |
2024-05-31 | 13D | Akari Therapeutics, Plc AKTX |
Patel Samir Rashmikant | 3,413,162,167 14.500% |
3,413,162,167 (New Position) |
Filing |